Abstract
We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.
| Original language | English (US) |
|---|---|
| Article number | e86 |
| Journal | Antimicrobial Stewardship and Healthcare Epidemiology |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| State | Published - Apr 1 2026 |
Bibliographical note
Publisher Copyright:© The Author(s), 2026. Published by Cambridge University Press.
PubMed: MeSH publication types
- Journal Article
Fingerprint
Dive into the research topics of 'Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS